AI-Enabled Drug Repurposing and Indication Expansion

Oct 29, 2026
Discovery Chemistry

• Assess how multimodal data integration reveals novel disease–target–compound relationships.
• Explore network-based and foundation model approaches for identifying new therapeutic indications.
• Evaluate how AI-driven repurposing strategies reduce development risk and compress time to market.

Speakers
Nikhil Pillai
Nikhil Pillai, Senior Principal Scientist in Quantitative Pharmacology–Pharmacometrics  - Sanofi